Desai Amita A, Alemayehu Hanna, Holcomb George W, St Peter Shawn D
Department of Surgery, Children's Mercy Hospital, Kansas City, MO.
Department of Surgery, Children's Mercy Hospital, Kansas City, MO.
J Pediatr Surg. 2015 Jun;50(6):912-4. doi: 10.1016/j.jpedsurg.2015.03.006. Epub 2015 Mar 14.
In a previous randomized trial, we found children with perforated appendicitis could be safely discharged prior to completion of a 5 day intravenous antibiotics course. To progress the protocol further, patients who met discharge criteria early were discharged without oral antibiotics if leukocyte counts were normal.
Children undergoing laparoscopic appendectomy for perforated appendicitis were prospectively observed after institution of a new antibiotic regimen consisting of daily intravenous dosing ceftriaxone/metronidazole while an inpatient. Patients discharged prior to 5 days were discharged home without oral amoxicillin-clavulanate if no leukocytosis at discharge. Outcomes were compared to the previous protocol of daily intravenous ceftriaxone/metronidazole with completion of a 7-day antibiotic course with amoxicillin-clavulanate of all patients discharged prior to 5 days.
540 patients (270 new protocol, 270 old protocol) were identified. There was no significant difference in patient demographics, admission leukocyte count, time to regular diet, or length of stay. Postoperative abscess occurred in 21.8% in the new protocol compared to 19.3% of the previous (P=0.5). There was a significant decrease in the number of patients discharged home on oral antibiotic therapy (P<0.001).
Patients meeting discharge criteria with normal leukocyte count prior to completion of 5 days IV antibiotic therapy can be safely discharged home without oral antibiotics after laparoscopic appendectomy for perforated appendicitis.
在之前的一项随机试验中,我们发现患有穿孔性阑尾炎的儿童在完成为期5天的静脉抗生素疗程之前可以安全出院。为了进一步推进该方案,如果白细胞计数正常,早期符合出院标准的患者可在不使用口服抗生素的情况下出院。
对接受腹腔镜穿孔性阑尾炎切除术的儿童在采用新的抗生素方案(住院期间每日静脉注射头孢曲松/甲硝唑)后进行前瞻性观察。在5天前出院的患者,如果出院时没有白细胞增多,则在不使用口服阿莫西林-克拉维酸的情况下出院回家。将结果与之前的方案进行比较,之前的方案是每日静脉注射头孢曲松/甲硝唑,并对所有在5天前出院的患者完成为期7天的阿莫西林-克拉维酸抗生素疗程。
共纳入540例患者(新方案组270例,旧方案组270例)。患者的人口统计学特征、入院时白细胞计数、恢复正常饮食的时间或住院时间均无显著差异。新方案组术后脓肿发生率为21.8%,而之前为19.3%(P=0.5)。接受口服抗生素治疗出院回家的患者数量显著减少(P<0.001)。
对于穿孔性阑尾炎行腹腔镜阑尾切除术后的患者,在完成5天静脉抗生素治疗前白细胞计数正常且符合出院标准的,可以在不使用口服抗生素的情况下安全出院回家。